Skip to content
979797

Drawing based on the label description. No photo yet.

“Delayed-Release Tablets: 40 mg pantoprazole, white to pale yellow colored, oval shape, biconvex, enteric-coated tablets, plain on one side and "97" printed with brown ink on the other side”

97 pill

Pill with imprint 97 is white, oval, 11 mm and has been identified as Pantoprazole Sodium D/R 40 mg. It is used for heartburn and acid reflux. It is supplied by Direct Rx.

Pantoprazole Sodium D/R 40 mg

Imprint
97
Strength
40 mg
Used for
Heartburn and acid reflux
Color
White
Shape
Oval
Size
11 mm
Score
No score line
Form
Tablet, delayed release
Manufacturer
Direct Rx
NDC
61919-700, 13668-429, 61919-700-90, 61919-700-40, 61919-700-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Pantoprazole Sodium D/R pills and guides

What is Pantoprazole Sodium D/R used for?

Pantoprazole Sodium D/R is used for heartburn and acid reflux.

Official uses from the US prescribing label

Pantoprazole sodium delayed-release tablets are indicated for:

1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD)

Pantoprazole sodium delayed-release tablets are indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (EE). For those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole sodium delayed-release tablets may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been established.

1.2 Maintenance of Healing of Erosive Esophagitis

Pantoprazole sodium delayed-release tablets are indicated for maintenance of healing of EE and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD. Controlled studies did not extend beyond 12 months.

1.3 Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome

Pantoprazole sodium delayed-release tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison (ZE) Syndrome.

From the FDA-approved label on DailyMed (published Oct 07, 2022).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 97 and the other side is plain.
  • It is white, oval, 11 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Pantoprazole Sodium

Inactive: Propylene Glycol, Mannitol, Hypromellose 2910 (3 Mpa.s), Talc, Triethyl Citrate, Hydroxypropyl Cellulose (1600000 Wamw), Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type A, Sodium Carbonate Decahydrate, Titanium Dioxide, Calcium Stearate, Crospovidone

Also distributed by

Direct_rx

Other pills with imprint 97

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.